Moderna (MRNA) Stock Pulls Back After Recent Strength

Moderna shares are down on Monday, pulling back following a recent report highlighting its latest cancer trial results.
Zacks.com on MSN

Moderna Stock on the Move: What Sparked the 13% Jump in the Past Week?

Shares of Moderna MRNA rose 13% in the past week after the company announced preliminary sales for the full-year 2025, as ...
Seeking Alpha

Moderna projects 10% growth next year; lifts outlook for year-end liquidity

Ahead of its Analyst Day event on Thursday, Moderna (MRNA) indicated ~10% revenue growth for next year and increased its outlook for year-end liquidity, following up to a $1.5B loan from Ares ...
Zacks Investment Research on MSN

MRNA & MRK's Personalized Cancer Therapy Delivers Strong 5-Year Data

Shares of Moderna MRNA were up 15.8% on Jan. 21, after the company and its partner Merck MRK announced positive median ...